- Home
- LICN vs MODD Comparison
LICN vs MODD Comparison
Compare LICN & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- MODD
- Stock Information
- Founded
- LICN 2004
- MODD 1998
- Country
- LICN China
- MODD United States
- Employees
- LICN N/A
- MODD N/A
- Industry
- LICN
- MODD Industrial Specialties
- Sector
- LICN
- MODD Health Care
- Exchange
- LICN Nasdaq
- MODD Nasdaq
- Market Cap
- LICN 83.8M
- MODD 67.4M
- IPO Year
- LICN 2023
- MODD N/A
- Fundamental
- Price
- LICN $0.16
- MODD $1.55
- Analyst Decision
- LICN
- MODD Buy
- Analyst Count
- LICN 0
- MODD 1
- Target Price
- LICN N/A
- MODD $5.00
- AVG Volume (30 Days)
- LICN 21.2M
- MODD 235.8K
- Earning Date
- LICN 12-24-2024
- MODD 02-11-2025
- Dividend Yield
- LICN N/A
- MODD N/A
- EPS Growth
- LICN 36.90
- MODD N/A
- EPS
- LICN 0.28
- MODD N/A
- Revenue
- LICN $41,929,000.00
- MODD N/A
- Revenue This Year
- LICN N/A
- MODD N/A
- Revenue Next Year
- LICN N/A
- MODD $830.43
- P/E Ratio
- LICN $0.61
- MODD N/A
- Revenue Growth
- LICN 24.86
- MODD N/A
- 52 Week Low
- LICN $0.15
- MODD $1.08
- 52 Week High
- LICN $2.44
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- LICN 19.85
- MODD 27.32
- Support Level
- LICN $0.15
- MODD $1.45
- Resistance Level
- LICN $0.19
- MODD $1.71
- Average True Range (ATR)
- LICN 0.23
- MODD 0.09
- MACD
- LICN -0.13
- MODD -0.00
- Stochastic Oscillator
- LICN 0.65
- MODD 29.24
About LICN Lichen China Limited
Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.